搜尋結果
Weight-loss drug Zepbound resolves sleep apnea in up to 52% of patients, Lilly says
Reuters· 3 小時前, opens new tab on Friday said its popular weight-loss drug Zepbound helped resolve moderate to ...
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of ...
CNBC· 3 小時前If cleared by the Food and Drug Administration, the company plans to launch Zepbound for ...
Tesla makes Musk best-paid CEO of all time and Fisker bites the dust
TechCrunch· 4 小時前Elon Musk just convinced Tesla shareholders to approve his $56 billion pay package, making him ...
US FDA approves Bristol Myers' colorectal cancer therapy
Reuters· 4 小時前The approval under the agency's accelerated process was based on an early- to mid-stage ...
Wall Street is set to wrap up a strong first half with a key inflation report on deck
CNBC· 5 小時前Stocks have defied all expectations at the midpoint of the year. While many investors came into ...
Altria’s Menthol E-Cigs Get FDA Nod as Menthol Debate Continues
Bloomberg· 5 小時前Have a confidential tip for our reporters? The US Food and Drug Administration said ... ...
Stocks making the biggest moves midday: Sarepta Therapeutics, Hertz Global, Asana and more
CNBC· 6 小時前Shares of the biopharma company surged 33% after the U.S. Food and Drug Administration approved ...
In a first, FDA authorizes flavored e-cigarettes from Altria's NJOY for sale in the US
Reuters· 6 小時前The U.S. Food and Drug Administration authorized four of Altria's menthol e-cigarettes for ...
Nearly $109 million in deposits held for fintech Yotta’s customers vanished in Synapse ...
CNBC· 7 小時前A network of eight banks held $109 million in deposits for Yotta customers as of April 11, ...
The Thrilla in Manila With Threat of Flotilla
Bloomberg· 8 小時前Beijing and Washington squeeze the Philippines as their superpower rivalry tightens in the ...